Evvy raises $40M as it seeks to further women’s health research with vaginal microbiome data

Women's health startup Evvy has secured $40 million in Series B funding to expand its work in vaginal microbiome research. Founded in 2021 by Priyanka Jain, Laine Bruzek, and Pita Navarro, Evvy is currently the only at-home CLIA-certified and CLEP-certified mNGS test for analyzing vaginal microbiomes. Users mail their swab samples to Evvy's lab, which then analyzes the data and shares results with registered clinicians on its platform.

CEO Jain explained that the company's goal is to build a comprehensive dataset linking microbiome biology, symptoms, interventions, and health outcomes to create a continuous feedback loop for improved care and the discovery of new biomarkers. Evvy's recent launch of AI assistant EvvyAI provides users with real-time vaginal health guidance based on the collected microbiome data.

The company is now venturing into the fertility space, studying the connection between vaginal microbiomes and conditions such as infertility, gynecological cancer, preterm birth, IVF success rates, and recurrent pregnancy loss. Jain emphasized the need for high-quality, representative data on female biology to advance precision medicine for women.